Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells - Wikidata - awgldk - TriplyDB

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells

http://www.wikidata.org/entity/Q33981572

about

HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function Limited durability of viral control following treated acute HIV infection Progress and controversies in developing cancer vaccines.CD4 T-cell immunotherapy for chronic viral infections and cancer IL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques.GagCM9-specific CD8+ T cells expressing limited public TCR clonotypes do not suppress SIV replication in vivo Impaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV Coinfection Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 Responsiveness CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21 Immune modulation through 4-1BB enhances SIV vaccine protection in non-human primates against SIVmac251 challenge A vaccine encoding conserved promiscuous HIV CD4 epitopes induces broad T cell responses in mice transgenic to multiple common HLA class II molecules Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602)The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.CD8+ T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variation.Immunological responses and long-term treatment interruption after human immunodeficiency virus type 1 (HIV-1) lipopeptide immunization of HIV-1-infected patients: the LIPTHERA study.Resisting immune exhaustion in HIV-1 infection.A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.Immune escape mutations detected within HIV-1 epitopes associated with viral control during treatment interruption Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R{alpha} (CD127) and perforin expression.HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells.CD4+ T cells modulate expansion and survival but not functional properties of effector and memory CD8+ T cells induced by malaria sporozoites Simian-human immunodeficiency infection--is the course set in the acute phase?Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles.Limited sequence evolution within persistently targeted CD8 epitopes in chronic human immunodeficiency virus type 1 infection.Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressors Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection CD39/adenosine pathway is involved in AIDS progression Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.Immunity to HIV in Early Life CD4+ T-cell help enhances NK cell function following therapeutic HIV-1 vaccination.Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection.Changes in function of HIV-specific T-cell responses with increasing time from infection.Tat(28-35)SL8-specific CD8+ T lymphocytes are more effective than Gag(181-189)CM9-specific CD8+ T lymphocytes at suppressing simian immunodeficiency virus replication in a functional in vitro assay.

P2860

Q24600313-954769FF-E43E-4E73-83C5-EE6198065C87 Q24804986-E0D7F012-8BDD-4F4E-98B9-494E90CA9702 Q24810256-107FBC94-9C8F-4D6B-877A-842355CE099D Q27022957-9A4D6505-A513-4F0B-8DA3-1B0F07FB186F Q27320132-655AF095-B71B-4322-A6FC-D2159506275F Q27324128-A7F85663-5FC3-46DA-8B33-F761A3370C8E Q27477797-16F5640B-7F41-4AFE-A021-DCA94F5B783E Q27478328-957B7B70-224B-49EE-9760-D1BBAD21BC91 Q27487966-723B4A29-A7AD-490A-8BF3-BC18854A68AD Q28307312-46AA1047-26E3-4033-81F7-1F3176F2FC5B Q28740359-2BA9727D-7EB2-42A1-9882-29BA2CEC087F Q28751663-12831101-4897-40CF-92C7-C9400BF4EC4F Q28754733-4203061B-2DB7-4373-B011-8B5B0F504FD7 Q29616205-523B6E36-ECFE-4755-A82B-AA4DE57E1942 Q29618956-D3ABEE42-5D95-4AEB-9149-799DC291D4E1 Q30411499-7B5D178B-B1A8-4C0A-9FFE-AB9CB59052BE Q30425111-6E7FF22D-74AD-4876-9765-8CBB295250AA Q30425914-4B353653-78B4-4BB1-8B58-91EBFF7CA6F5 Q33262230-9CED8728-415C-439D-BA86-D11EF07B2C75 Q33305428-0B9D601D-EE71-482F-9163-A3588C34E47A Q33313949-B60EB785-5640-4854-91B1-11C3B97E0ADB Q33332291-01335DE7-1F15-4A9E-A16E-3C09B213AAAF Q33645564-CDB55796-8F90-4A55-9239-DFFB0000CD27 Q33731771-75268D45-433E-42CC-A9E0-7408D36A56D4 Q33745356-3F190A57-EF18-4A2C-A43A-707C338620DF Q33769360-184452D4-D770-4BD9-8137-2E62EC43F353 Q33772204-A43521BE-BD2B-4125-97DC-5B6811844516 Q33796468-B2160186-B597-457D-9963-A63E41D16283 Q33831899-92018C9A-AC2C-4309-9909-24F154C37026 Q33839468-4C1FF857-AE95-4C52-A316-80D9D721498B Q33843340-640EC06B-BC70-4D3E-B88A-F0A0E693C43F Q33869222-A43143B8-E13E-4E6E-AE1B-4AE5AF501705 Q33911928-DF5D6B19-F331-435B-A17C-214E6ECA582A Q33959186-0D5B36B1-68A9-4D03-AD11-128012240FAF Q34009945-A1E67503-47A1-4E7C-8614-CAE8B6B1B326 Q34033051-7683DA2B-0189-4C87-98D1-ED56678065FE Q34057778-8C5E0CB7-E190-46E7-A555-462146F43A28 Q34089124-55293AA8-C16F-4A25-AF4A-BE288240A41B Q34142433-DDA7CA83-93F7-41C6-92CA-A09767B9275B Q34142916-D6BC9A90-2B09-44C6-A6EE-E73DE3432AF2

P2860

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells

http://www.wikidata.org/entity/Q33981572

description

2004 nî lūn-bûn

@nan

2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Loss of HIV-1-specific CD8+ T ...... ed HIV-1-specific CD4+ T cells

@ast

Loss of HIV-1-specific CD8+ T ...... ed HIV-1-specific CD4+ T cells

@en

type

label

Loss of HIV-1-specific CD8+ T ...... ed HIV-1-specific CD4+ T cells

@ast

Loss of HIV-1-specific CD8+ T ...... ed HIV-1-specific CD4+ T cells

@en

prefLabel

Loss of HIV-1-specific CD8+ T ...... ed HIV-1-specific CD4+ T cells

@ast

Loss of HIV-1-specific CD8+ T ...... ed HIV-1-specific CD4+ T cells

@en

P1433

Q33981572-626A80AD-A59F-412C-B8F6-6BDE4E470F47

P1476

Q33981572-9B0673F5-8F70-49E7-9582-573DBB97EBC9

P2093

Q33981572-0293F7B2-88E2-473D-A4F3-4C2E509F1302

Q33981572-09D602B5-9FF1-4679-8411-B48B1BA140E1

Q33981572-19F8A123-FA78-4294-A340-BB5D973F13BF

Q33981572-21466266-3EC4-4A5D-8293-80DEADC295B6

Q33981572-5C903B7D-C735-4C0C-B0E2-BF860BABB741

Q33981572-799D6897-ECE2-4D12-8BFB-25FB45E704B3

Q33981572-7A0111FA-2EE4-414F-95D5-2F5662161EB4

Q33981572-88EBB872-C2F4-4CA2-AB6A-056D0DECB4F1

Q33981572-C1969811-653E-4CF2-82B6-2DC4795567F4

Q33981572-D3C33AB5-12AA-4750-8AEC-E25AF7BABFA4

P2860

Q33981572-09DA5D45-4BF7-4E5E-9719-E3802DCC0408

Q33981572-1E0FD42C-D699-4DBB-ADE8-D56F64EEC097

Q33981572-2B094DA2-DB74-43E9-AF45-59167556C1FE

Q33981572-33D9D795-8DCB-4725-A53A-A4321B01CCED

Q33981572-36DFDC31-B17B-448E-9C82-1B6AD730D8E5

Q33981572-3EE53D24-E165-4DB3-9735-6E44FB9EB9CA

Q33981572-50929E9F-A8BF-46B4-949D-3730727AEED0

Q33981572-659FF9C4-2055-4929-BCB6-EE63E3DF0076

Q33981572-6E35E3A1-5574-44C5-B231-1A41CAB60392

Q33981572-71D6A13C-3113-4798-A2AD-6478A4DAB716

P304

Q33981572-C0917C2C-E9B9-4973-B103-52039ECBDEE3

P31

Q33981572-FB26C824-976A-404B-87B7-CB90429A7D10

P356

Q33981572-6234CD88-34A0-4614-817E-0794657E8FFF

P407

Q33981572-8ADE6874-3D59-473B-91D2-769A9A75C5C6

P433

Q33981572-FD243100-9E00-4DBE-AB08-49F4F78F321A

P478

Q33981572-A68397EC-9D9B-445A-82A5-38E1C1FD5476

P50

Q33981572-210D0241-BC06-4DB9-808E-8AF91F467EAB

Q33981572-218376DA-6989-46CB-9015-B61F02452DA4

Q33981572-80A310D0-ECCD-4AF7-AD8C-506AC759E269

Q33981572-FB6FBFC8-0C7F-441D-A111-13C21B886EDE

P577

Q33981572-4B22FC45-F7B4-4BDE-A3EA-A1C26CAC8D97

P5875

Q33981572-CB492CCF-B904-466C-8958-3A333035D76E

P698

Q33981572-179C8E02-B86C-466C-B83C-B120F586C599

P921

Q33981572-F8A27015-C545-45F8-B748-A7C8CB39824B

P932

Q33981572-51845760-742B-4546-A45D-C01EC7754BAE

P356

P1433

Journal of Experimental Medicine

P1476

Loss of HIV-1-specific CD8+ T ...... ed HIV-1-specific CD4+ T cells

@en

P2093

Alysse Wurcel

http://www.w3.org/2001/XMLSchema#string

Daniel Cohen

http://www.w3.org/2001/XMLSchema#string

Daniel E Kaufmann

http://www.w3.org/2001/XMLSchema#string

David Stone

http://www.w3.org/2001/XMLSchema#string

Eunice Pae

http://www.w3.org/2001/XMLSchema#string

Galit Alter

http://www.w3.org/2001/XMLSchema#string

Gregory K Robbins

http://www.w3.org/2001/XMLSchema#string

Mary N Johnston

http://www.w3.org/2001/XMLSchema#string

Marylyn M Addo

http://www.w3.org/2001/XMLSchema#string

Mathias Lichterfeld

http://www.w3.org/2001/XMLSchema#string

P2860

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection

Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection

Acute human immunodeficiency virus type 1 infection.

Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

P304

701-712

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20041270

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

200

http://www.w3.org/2001/XMLSchema#string

P50

Bruce D. Walker

Eric S Rosenberg

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8332711

http://www.w3.org/2001/XMLSchema#string

P698

15381726

http://www.w3.org/2001/XMLSchema#string

P921

P932

2211961

http://www.w3.org/2001/XMLSchema#string